Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Pancreatic Cancer

Clinical trial NCT04106856 · COMPLETED

Trial details

NCT number: NCT04106856
Sponsor: University of Utah
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Borderline Resectable Pancreatic Adenocarcinoma Locally Advanced Pancreatic Ductal Adenocarcinoma Locally Advanced Unresectable Pancreatic Adenocarcinoma Stage II Pancreatic Cancer AJCC v8 Stage IIA Pancreatic Cancer AJCC v8 Stage IIB Pancreatic Cancer AJCC v8 Stage III Pancreatic Cancer AJCC v8

Start date: 2019-08-08
Primary completion: 2024-12-06
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.